Stocks
Funds
Screener
Sectors
Watchlists

Latest Column Group LLC Stock Portfolio

Column Group LLC Performance:
2025 Q4: -4.72%YTD: 20.08%2024: -53.93%

Performance for 2025 Q4 is -4.72%, and YTD is 20.08%, and 2024 is -53.93%.

About Column Group LLC and 13F Hedge Fund Stock Holdings

On 2026-02-13, the fund reported it's updated stock portfolio. In the 13F Holdings report, Column Group LLC reported an equity portfolio of $82.8 Millions as of 31 Dec, 2025.

The top stock holdings of Column Group LLC are SRZN, ORIC, TNYA. The fund has invested 50.5% of it's portfolio in SURROZEN, INC. and 35% of portfolio in ORIC PHARMACEUTICALS INC.

They significantly reduced their stock positions in RAPT THERAPEUTICS INC (RAPT). The fund showed a lot of confidence in some stocks as they added substantially to SURROZEN, INC. (SRZN).

Column Group LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Column Group LLC made a return of -4.72% in the last quarter. In trailing 12 months, it's portfolio return was 20.08%.
  • Performance
  • S&P 500

New Buys

No new stocks were added by Column Group LLC

Additions

Ticker% Inc.
surrozen, inc.23.44

Additions to existing portfolio by Column Group LLC

Reductions

Ticker% Reduced
rapt therapeutics inc-5.9

Column Group LLC reduced stake in above stock

Sold off

None of the stocks were completely sold off by Column Group LLC

Sector Distribution

Column Group LLC has about 100% of it's holdings in Healthcare sector.

Sector%
Healthcare100

Market Cap. Distribution

Column Group LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
MICRO-CAP58.6
SMALL-CAP41.4

Stocks belong to which Index?

About 49.5% of the stocks held by Column Group LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others50.5
RUSSELL 200049.5
Top 5 Winners (%)%
RVMD
revolution medicines inc
70.6 %
SRZN
surrozen, inc.
63.6 %
RAPT
rapt therapeutics inc
30.4 %
Top 5 Winners ($)$
SRZN
surrozen, inc.
16.3 M
RAPT
rapt therapeutics inc
1.3 M
RVMD
revolution medicines inc
0.0 M
Top 5 Losers (%)%
TNYA
tenaya therapeutics, inc.
-54.9 %
ORIC
oric pharmaceuticals inc.
-31.8 %
Top 5 Losers ($)$
ORIC
oric pharmaceuticals inc.
-13.5 M
TNYA
tenaya therapeutics, inc.
-8.2 M

Column Group LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Column Group LLC

Column Group LLC has 5 stocks in it's portfolio. ORIC proved to be the most loss making stock for the portfolio. SRZN was the most profitable stock for Column Group LLC last quarter.

Last Reported on: 13 Feb, 2026
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions